1
Return

Molecular changes during AT/RT progression associated with epithelial–mesenchymal transition and extracellular matrix changes

delete2026-07-01
delete0
delete
OA
AI
L
Lea Altendorf
A
Anton Althammer
R
Rajanya Roy
K
Karoline Hack
F
Flavia W. de Faria
A
Arend Koch
V
Vanessa Thaden
M
Melanie Schoof
M
Martin U. Schuhmann
P
Peter Hauser
P
Pascal D. Johann
M
Martin Hasselblatt
M
Michael C. Frühwald
K
Kornelius Kerl
U
Ulrich Schüller *
DOI:10.1007/s00401-026-03050-1delete
deleteOriginal
deleteShare
deleteSave
View PDF
Abstract

Abstract

En 中文
Atypical teratoid/rhabdoid tumors (AT/RT) are the most common malignant brain tumors during infancy and associated with a dismal prognosis. The majority of patients suffer from tumor progression or recurrence, but underlying mechanisms remain unknown. To better understand such mechanisms, we performed single-nucleus RNA sequencing (snRNAseq) of eight paired primary tumors and recurrences. Tumor cells and cells of the tumor microenvironment (TME) were analyzed separately. Potentially therapy-resistant tumor cells were identified through the comparison of global gene expression profiles between primary and recurrent tumor cell populations using CIBERSORT. Histopathology, in vitro experiments, bulk RNA sequencing, and survival analysis were performed for validation. Paired primary and recurrent AT/RT showed significant differences in their gene expression profiles. Potentially therapy-resistant AT/RT-MYC tumor cells revealed changes in the extracellular matrix (ECM) as well as altered developmental processes and immune signaling pathways. Respective gene signatures were correlated with inferior survival in AT/RT-MYC patients. Tumor cells of relapsed AT/RT-MYC underwent partial epithelial–mesenchymal transition (pEMT), a feature that was confirmed by immunohistochemistry (IHC) and by analyzing AT/RT cells after standard therapy in vitro. Together, we identified potential mechanisms of tumor relapse and therapy resistance in AT/RT, which could be employed to improve therapy in future.
Keywords:
AT/RT
Tumor recurrence
Therapy resistance
Single-nucleus RNA sequencing
pEMT
AI Summary

AI Summary

Key information extracted from the uploaded paper, including a brief overview, abstract, background, key highlights, visual analysis, and future outlook.

Journal

Acta Neuropathologica cover
Acta Neuropathologica
IF:
9.3
Papers:
8.3K
Citations:
2.5W

Organization

D
Department of Pediatric Hematology and Oncology
Scholars:
103
Papers: 58
Citations: 0
D
department of neurosurgery
Scholars:
4.0K
Papers: 1.2K
Citations: 1
S
second department of pediatrics
Scholars:
5
Papers: 2
Citations: 0
S
swabian children's cancer center augsburg
Scholars:
3
Papers: 1
Citations: 0
I
Institute of Neuropathology
Scholars:
76
Papers: 36
Citations: 0
Cited Papers

Cited Papers

Citing Papers

Citing Papers